MM retire, new CEO and Genevant/3rd party deals | ABUS Message Board Posts

Arbutus Biopharma

  ABUS website

ABUS   /  Message Board  /  Read Message

 

 






Keyword
Subject
Between
and
Rec'd By
Authored By
Minimum Recs
  
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board
Msg  34265 of 34949  at  4/12/2018 5:52:38 PM  by

liuyiiv


MM retire, new CEO and Genevant/3rd party deals

While we won't see meaningful readouts from HBV trials any time soon, I speculate that more changes are coming after Genevant deal:

1. MM retires. Quite a few of people on this board predicted this during Acuitas trial a few weeks ago. With LNP handed over, we need a new CEO with proven experience in the infectious disease field.

2. 3rd party deals coming. The market is muted on this deal today. The selling on news is not too bad. If we hold up in the next few days. I speculate deals will start flow in from Genevant and 3rd parties. If an IPO is needed soon, some decent deals on file would for sure help the pitch, when "5-10 candidates" are still 2 years away.


     e-mail to a friend      printer-friendly     add to library      
| More
Recs: 1     Views: 442
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board






Financial Market Data provided by
.


Loading...